Literature DB >> 5044783

Quantitative composition of nasal secretions in normal subjects.

M I Lorin, P F Gaerlan, I D Mandel.   

Abstract

Mesh：

Substances：

Year:  1972        PMID： 5044783

Source DB:  PubMed          Journal:  J Lab Clin Med        ISSN： 0022-2143


× No keyword cloud information.
  16 in total

1.  Characterization of IsaA and SceD, two putative lytic transglycosylases of Staphylococcus aureus.

Authors:  Melanie R Stapleton; Malcolm J Horsburgh; Emma J Hayhurst; Lynda Wright; Ing-Marie Jonsson; Andrej Tarkowski; John F Kokai-Kun; James J Mond; Simon J Foster
Journal:  J Bacteriol       Date:  2007-08-03       Impact factor: 3.490

2.  Ultrastructural localization of sialylated glycoconjugates in cells of the salamander olfactory mucosa using lectin cytochemistry.

Authors:  J D Foster; M L Getchell; T V Getchell
Journal:  Cell Tissue Res       Date:  1992-01       Impact factor: 5.249

3.  Competition among Nasal Bacteria Suggests a Role for Siderophore-Mediated Interactions in Shaping the Human Nasal Microbiota.

Authors:  Reed M Stubbendieck; Daniel S May; Marc G Chevrette; Mia I Temkin; Evelyn Wendt-Pienkowski; Julian Cagnazzo; Caitlin M Carlson; James E Gern; Cameron R Currie
Journal:  Appl Environ Microbiol       Date:  2019-05-02       Impact factor: 4.792

4.  Staphylococcus aureus counters phosphate limitation by scavenging wall teichoic acids from other staphylococci via the teichoicase GlpQ.

Authors:  Ana Maria Jorge; Jonathan Schneider; Sandra Unsleber; Guoqing Xia; Christoph Mayer; Andreas Peschel
Journal:  J Biol Chem       Date:  2018-08-01       Impact factor: 5.157

5.  In vitro antiviral activity of AG7088, a potent inhibitor of human rhinovirus 3C protease.

Authors:  A K Patick; S L Binford; M A Brothers; R L Jackson; C E Ford; M D Diem; F Maldonado; P S Dragovich; R Zhou; T J Prins; S A Fuhrman; J W Meador; L S Zalman; D A Matthews; S T Worland
Journal:  Antimicrob Agents Chemother       Date:  1999-10       Impact factor: 5.191

Review 6.  Intranasal antibody prophylaxis for protection against viral disease.

Authors:  R Weltzin; T P Monath
Journal:  Clin Microbiol Rev       Date:  1999-07       Impact factor: 26.132

7.  Intranasal delivery of Norwalk virus-like particles formulated in an in situ gelling, dry powder vaccine.

Authors:  Lissette S Velasquez; Samantha Shira; Alice N Berta; Jacquelyn Kilbourne; Babu M Medi; Ian Tizard; Yawei Ni; Charles J Arntzen; Melissa M Herbst-Kralovetz
Journal:  Vaccine       Date:  2011-06-02       Impact factor: 3.641

8.  Formulation and evaluation of in situ gelling systems for intranasal administration of gastrodin.

Authors:  Zheng Cai; Xiangrong Song; Feng Sun; Zhaoxiang Yang; Shixiang Hou; Zhongqiu Liu
Journal:  AAPS PharmSciTech       Date:  2011-08-31       Impact factor: 3.246

9.  An in vitro model for studying the effects of pharmacological agents on human ciliary beat frequency: effects of lignocaine.

Authors:  J Rutland; W Griffin; P J Cole
Journal:  Br J Clin Pharmacol       Date:  1982-05       Impact factor: 4.335

10.  New method to assess dilution of secretions for immunological and microbiological assays.

Authors:  A Virolainen; M J Mäkelä; E Esko; J Jero; G Alfthan; J Sundvall; M Leinonen
Journal:  J Clin Microbiol       Date:  1993-05       Impact factor: 5.948
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.